Indeed, tumors of advanced-stage NB patients have a good prognosis if characterized by elevated levels of DPYSL3, and even in high-risk NB patients the levels of DPYSL3 mark those patients who may have a better overall survival [71]. This evidence concerns the gene DPYSL3 and neuroblastoma.